
HIV/HCV: Closing the Gap
Patients who are co-infected with human immunodeficiency virus (HIV) and hepatitis C virus (HCV) have long represented a special population of patients with a unique set of challenges and barriers to HCV treatment access. Â FDA identifies HIV/HCV co-infected patients as a population with an unmet medical need due to the more rapid progression of liver […]